Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments that help customers manage samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. Services include sample storage, genomic sequencing, gene synthesis, laboratory processing and analysis, biospecimen procurement, and other support services. The company serves pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. Azenta was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. The company was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
| Symbol | AZTA |
|---|---|
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| CEO | Martin D. Madaus |
| Employees | 2900 |
| Headquarters | Burlington, MA, US |
| IPO | 1995-02-02 |
| Website | www.azenta.com |